Clinical Trials Sponsored by Venture Strategies for Health and Development

Total 1475 results

Centre for Addiction and Mental Health

Recruiting

The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia

Schizophrenia;Schizoaffective

Canada
Centre for Addiction and Mental Health

Active, not recruiting

Neuroinflammation in COVID-19 and Depression

Covid19 | Major Depressive Episode

Canada
Centre for Addiction and Mental Health

Completed

Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia

Healthy | Schizophrenia

Canada
Centre for Addiction and Mental Health

Completed

A Dietary Supplement for Mood Symptoms in Early Postpartum: A Double Blind Randomized Placebo Controlled Trial

Healthy | Postpartum Blues

Canada
Centre for Addiction and Mental Health

Completed

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia (rTMSCANSZ)

Schizophrenia | Cognition | Cannabis Use Disorder | Repetitive Transcranial Magnetic Stimulation (rTMS)

Canada
Centre for Addiction and Mental Health

Completed

Effects of Cannabis Abstinence on Symptoms and Cognition in Depression

Major Depressive Disorder | Cognition | Cannabis Use Disorder

Canada
Centre for Addiction and Mental Health

Completed

Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders) (SURE-ECT)

Depression

Canada
Centre for Addiction and Mental Health

Completed

Role of BP1.3656 on Alcohol Responses

Alcohol Use Disorder

Canada
Centre for Addiction and Mental Health

Completed

Targeting Mailed Nicotine Patch Distribution Interventions to Rural Regions of Canada

Tobacco Use Cessation

Canada
Centre for Addiction and Mental Health

Completed

Dose-response of Cannabis and Driving

Cognitive Impairment | Driving Impaired | Abuse Cannabis

Canada
Centre for Addiction and Mental Health

Completed

Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Delusional Disorder | Psychotic Disorder

Canada
Centre for Addiction and Mental Health

Completed

Offering Nicotine Patches to All Households in a Municipality With High Smoking Rates

Tobacco Use Cessation

Canada
Centre for Addiction and Mental Health

Completed

Xyrem and Brain Dopamine in Narcolepsy

Healthy Controls | Narcolepsy With Cataplexy

Canada
Centre for Addiction and Mental Health

Completed

Personalized Feedback Intervention to Reduce Risky Cannabis Use.

Cannabis Use

Canada
Centre for Addiction and Mental Health

Completed

Non-invasive Brain Stimulation Using Transcranial Direct Current Stimulation for Neuropsychiatric Symptoms of Dementia

Dementia; Alzheimer, Mixed Type (Etiology)

Canada
Centre for Addiction and Mental Health

Completed

Feasibility and Outcomes of a Digital Health Support for the Schizophrenia Spectrum

Schizophrenia Spectrum and Other Psychotic Disorders

Canada
Centre for Addiction and Mental Health

Unknown

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Canada
Centre for Addiction and Mental Health

Completed

Neuroimaging MAO-B in Medication Free TR-MDD Using Novel Tracer (DETB)

Major Depressive Disorder

Canada
Centre for Addiction and Mental Health

Completed

Transdiagnostic iCBT for Depression and Anxiety

Generalized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic Disorder

Canada
Centre for Addiction and Mental Health

Completed

Melatonin Use for Sleep Problems in Alcohol Dependent Patients

Alcohol-Related Disorders

Canada
Centre for Addiction and Mental Health

Completed

Nicotine Metabolizers and [11C]-(+)-PHNO (MET)

Nicotine Dependence

Canada
Centre for Addiction and Mental Health

Completed

Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness

Diabetes Mellitus, Type 2 | Schizophrenia

Canada
Centre for Addiction and Mental Health

Completed

Efficacy and Biological Targets of Response to rTMS Therapy in Youth Depression

Depressive Symptoms

Canada
Centre for Addiction and Mental Health

Completed

Commitment and Motivation in a Brief DBT Intervention for Self Harm

Acceptance Processes | Psychological Orientation

Canada
Centre for Addiction and Mental Health

Completed

Antipsychotic Augmentation With L-Dopa

Schizophrenia

Canada
Centre for Addiction and Mental Health

Terminated

Brief Motivational Enhancement Therapy for Concurrent Disorders

Substance Use | Psychosis

Canada
Centre for Addiction and Mental Health

Completed

Desvenlafaxine Monotherapy in Dysthymia

Dysthymic Disorder

Canada
Centre for Addiction and Mental Health

Completed

The Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Working Memory

Schizophrenia

Canada
Centre for Addiction and Mental Health

Completed

Treating Refractory Obsessive Compulsive Disorder With rTMS

Obsessive Compulsive Disorder

Canada
Centre for Addiction and Mental Health

Withdrawn

A Randomized Control Trial Examining Two Treatments for Problem Gambling

Anger | Gambling, Pathological
Centre for Addiction and Mental Health

Completed

Cognitive Behavioral Therapy for Early-Onset Depression

Major Depressive Disorder | Dysthymic Disorder

Canada
Centre for Addiction and Mental Health

Completed

Development and Validation of a Mindfulness Intervention for Problem Gambling: An Exploratory Study

Gambling

Canada
Centre for Addiction and Mental Health

Recruiting

Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents (MATCH-DB)

Emotional Disorder | Attention Deficit Hyperactivity Disorder | Conduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder | Behavioural Disorder

Canada
Centre for Addiction and Mental Health

Recruiting

A4i-O: A Platform for Complex Behavioral Health to Address OUD

Opioid-Related Disorders | Mental Health Wellness 1 | Mobile Phone Use | Comorbidities and Coexisting Conditions | Relationship, Professional Patient

Canada
Centre for Addiction and Mental Health

Recruiting

Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability (METIDD)

Obesity | Intellectual Disability | Developmental Disability

Canada
Centre for Addiction and Mental Health

Recruiting

Pragmatic Patient-oriented Extension Study of Dialectical Behavior Therapy Booster Sessions for Youth With and/or at Familial Risk for Bipolar Disorder (DB2)

Bipolar Disorder

Canada
Centre for Addiction and Mental Health

Recruiting

Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia

Schizophrenia | Schizoaffective

Canada
Centre for Addiction and Mental Health

Recruiting

Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression (DEEPP)

Suicidality | Bipolar Disorder (BD)

Canada
Centre for Addiction and Mental Health

Recruiting

rTMS for Depression in Young Adults With Autism (rTMS-MDD)

Autism Spectrum Disorder | Major Depressive Disorder

Canada
Centre for Addiction and Mental Health

Recruiting

Extended Effects of Cannabis Abstinence on Clinical Symptoms and Cognition in Depression

Cognitive Impairment | Major Depressive Disorder | Cannabis Use

Canada
Centre for Addiction and Mental Health

Recruiting

Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment (PAS-MCI)

Mild Cognitive Impairment | Memory Impairment

Canada
Centre for Addiction and Mental Health

Recruiting

Development and Evaluation of Culturally Adapted CBT for South Asian Canadians (CaCBT)

Depression | Anxiety

Canada
Centre for Addiction and Mental Health

Recruiting

The Effects of tDCS on Illness Awareness in Schizophrenia

Schizophrenia

Canada
Centre for Addiction and Mental Health

Completed

Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms

Cigarette Smoking Behavior

Canada
Centre for Addiction and Mental Health

Completed

Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic

Major Depressive Disorder

Canada
Centre for Addiction and Mental Health

Active, not recruiting

Effects of a Mindfulness App for Outpatients Waitlisted for Psychological Interventions

Mental Disorder

Canada
Centre for Addiction and Mental Health

Terminated

A Pilot Trial of Nabilone for the Treatment of Obesity

Obesity

Canada
Centre for Addiction and Mental Health

Enrolling by invitation

Trial of a Brief Psychological Intervention for Suicidal Patients With Borderline Personality Disorder in the Emergency Department

Borderline Personality Disorder | Suicide and Self-harm

Canada
Centre for Addiction and Mental Health

Completed

Technology-enabled Collaborative Care for Diabetes Management During COVID-19

Type 2 Diabetes

Canada
Centre for Addiction and Mental Health

Completed

A Study of Cognitive Adaptation Training in Inpatient Forensic Environments (finCAT)

Schizophrenia

Canada

Clinical Trials Sponsored by Venture Strategies for Health and Development

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations